PL2089031T3 - Redukowanie nadwagi lub otyłości - Google Patents
Redukowanie nadwagi lub otyłościInfo
- Publication number
- PL2089031T3 PL2089031T3 PL07766498T PL07766498T PL2089031T3 PL 2089031 T3 PL2089031 T3 PL 2089031T3 PL 07766498 T PL07766498 T PL 07766498T PL 07766498 T PL07766498 T PL 07766498T PL 2089031 T3 PL2089031 T3 PL 2089031T3
- Authority
- PL
- Poland
- Prior art keywords
- reduction
- overweight
- obesity
- weight gain
- bgp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85611706P | 2006-11-02 | 2006-11-02 | |
US11/687,945 US7763601B2 (en) | 2006-11-02 | 2007-03-19 | Prevention and treatment of obesity |
EP07766498A EP2089031B1 (en) | 2006-11-02 | 2007-07-23 | Reduction of overweight or obesity |
PCT/HU2007/000066 WO2008053256A1 (en) | 2006-11-02 | 2007-07-23 | Reduction of overweight or obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2089031T3 true PL2089031T3 (pl) | 2011-05-31 |
Family
ID=38592002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07766498T PL2089031T3 (pl) | 2006-11-02 | 2007-07-23 | Redukowanie nadwagi lub otyłości |
Country Status (20)
Country | Link |
---|---|
US (1) | US7763601B2 (pl) |
EP (1) | EP2089031B1 (pl) |
JP (1) | JP2010509199A (pl) |
KR (1) | KR20090082442A (pl) |
AT (1) | ATE489090T1 (pl) |
AU (1) | AU2007315931A1 (pl) |
BR (1) | BRPI0717867A2 (pl) |
CA (1) | CA2668382A1 (pl) |
DE (1) | DE602007010819D1 (pl) |
DK (1) | DK2089031T3 (pl) |
HK (1) | HK1131737A1 (pl) |
HR (1) | HRP20110023T1 (pl) |
IL (1) | IL198296A (pl) |
MX (1) | MX2009004538A (pl) |
NO (1) | NO20092025L (pl) |
PL (1) | PL2089031T3 (pl) |
PT (1) | PT2089031E (pl) |
RU (1) | RU2443417C2 (pl) |
SI (1) | SI2089031T1 (pl) |
WO (1) | WO2008053256A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
EP3788877A1 (en) * | 2007-04-11 | 2021-03-10 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
WO2009074835A1 (en) * | 2007-12-10 | 2009-06-18 | N-Gene Research Laboratories Inc. | Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity |
HUP1100444A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
HUP1100445A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187220A (en) | 1977-08-30 | 1980-02-05 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
US4287220A (en) * | 1980-02-19 | 1981-09-01 | Frito-Lay, Inc. | Hull containing compositions |
HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
HU9502843D0 (en) | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
US6884424B2 (en) | 1995-12-22 | 2005-04-26 | N-Gene Research Laboratories Inc. | Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight |
US6458371B1 (en) | 1995-12-22 | 2002-10-01 | Medgene, Limited | Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin |
HU9701081D0 (en) | 1997-06-23 | 1997-08-28 | Gene Research Lab Inc N | Pharmaceutical composition of antitumoral activity |
HUP9701080A3 (en) | 1997-06-23 | 1999-05-28 | Gene Res Lab Inc New York N | Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative |
AU5296799A (en) | 1998-08-03 | 2000-02-28 | N-Gene Kutato Kft. | Pharmaceutical compositions against autoimmune diseases |
UA65635C2 (uk) * | 1998-09-03 | 2004-04-15 | Н-Гене Кутато Кфт. | НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ |
CA2452558C (en) | 2001-07-17 | 2009-12-22 | N-Gene Research Laboratories Inc. | A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
HUP0401177A2 (en) | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition for increasing the mitochondrial genesis |
HUP0401176A2 (en) | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition having prpkinetic effect |
HUP0500145A2 (en) | 2005-01-28 | 2006-11-28 | Gene Res Lab N | Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases |
CN101534836B (zh) | 2006-09-05 | 2011-09-28 | 彼帕科学公司 | Parp抑制剂在制备治疗肥胖症的药物中的用途 |
-
2007
- 2007-03-19 US US11/687,945 patent/US7763601B2/en not_active Expired - Fee Related
- 2007-07-23 CA CA002668382A patent/CA2668382A1/en not_active Abandoned
- 2007-07-23 DE DE602007010819T patent/DE602007010819D1/de active Active
- 2007-07-23 RU RU2009119567/15A patent/RU2443417C2/ru not_active IP Right Cessation
- 2007-07-23 AT AT07766498T patent/ATE489090T1/de active
- 2007-07-23 PT PT07766498T patent/PT2089031E/pt unknown
- 2007-07-23 WO PCT/HU2007/000066 patent/WO2008053256A1/en active Application Filing
- 2007-07-23 JP JP2009535137A patent/JP2010509199A/ja active Pending
- 2007-07-23 AU AU2007315931A patent/AU2007315931A1/en not_active Abandoned
- 2007-07-23 EP EP07766498A patent/EP2089031B1/en active Active
- 2007-07-23 PL PL07766498T patent/PL2089031T3/pl unknown
- 2007-07-23 DK DK07766498.5T patent/DK2089031T3/da active
- 2007-07-23 MX MX2009004538A patent/MX2009004538A/es active IP Right Grant
- 2007-07-23 BR BRPI0717867-0A patent/BRPI0717867A2/pt not_active IP Right Cessation
- 2007-07-23 SI SI200730517T patent/SI2089031T1/sl unknown
- 2007-07-23 KR KR1020097011079A patent/KR20090082442A/ko not_active Application Discontinuation
-
2009
- 2009-04-22 IL IL198296A patent/IL198296A/en not_active IP Right Cessation
- 2009-05-25 NO NO20092025A patent/NO20092025L/no not_active Application Discontinuation
- 2009-09-25 HK HK09108841.5A patent/HK1131737A1/xx not_active IP Right Cessation
-
2011
- 2011-01-13 HR HR20110023T patent/HRP20110023T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
SI2089031T1 (sl) | 2011-04-29 |
EP2089031A1 (en) | 2009-08-19 |
IL198296A (en) | 2011-09-27 |
BRPI0717867A2 (pt) | 2013-10-29 |
WO2008053256A1 (en) | 2008-05-08 |
PT2089031E (pt) | 2011-02-24 |
NO20092025L (no) | 2009-06-02 |
EP2089031B1 (en) | 2010-11-24 |
DK2089031T3 (da) | 2011-02-14 |
KR20090082442A (ko) | 2009-07-30 |
ATE489090T1 (de) | 2010-12-15 |
DE602007010819D1 (de) | 2011-01-05 |
MX2009004538A (es) | 2009-05-22 |
IL198296A0 (en) | 2010-02-17 |
US7763601B2 (en) | 2010-07-27 |
RU2443417C2 (ru) | 2012-02-27 |
AU2007315931A1 (en) | 2008-05-08 |
HK1131737A1 (en) | 2010-02-05 |
CA2668382A1 (en) | 2008-05-08 |
JP2010509199A (ja) | 2010-03-25 |
RU2009119567A (ru) | 2010-12-10 |
US20080108673A1 (en) | 2008-05-08 |
HRP20110023T1 (hr) | 2011-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1131737A1 (en) | Reduction of overweight or obesity | |
EP1730163A4 (en) | Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid | |
WO2007087395A3 (en) | UNSATURATED mTOR INHIBITORS | |
MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
MX2012007375A (es) | 3-ceto-n-propargil 1-aminoindano. | |
WO2008142055A3 (en) | Antiviral agents | |
MX2012000414A (es) | Derivados piridin-4-ilo. | |
WO2009016462A3 (en) | Substituted bicyclolactam compounds | |
TNSN08173A1 (en) | Dispersible tablets comprising deferasirox | |
SG170795A1 (en) | Methods for improving the pharmacokinetics of hiv integrase inhibitors | |
WO2010066629A3 (en) | Novel azaindoles | |
WO2006067392A3 (en) | Indole derivatives for the treatment of tuberculosis | |
WO2008096820A1 (ja) | ビフェニル誘導体 | |
WO2005123049A3 (en) | A pharmaceutical composition for increasing the mitochondrial genesis | |
TN2012000092A1 (en) | Therapeutic agent for mood disorders | |
GEP20146168B (en) | Pyrazinooxazepine derivatives | |
IL192190A0 (en) | Process for the preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid | |
TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
IL181267A0 (en) | Vla-4 antagonists | |
GB2421442B (en) | Tidal gas resuscitation monitor | |
WO2007120848A3 (en) | Devices, systems and methods using magnetic force systems in the tongue | |
HK1131736A1 (en) | A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect | |
WO2011058336A3 (en) | Tablet comprising gum arabic | |
TN2012000093A1 (en) | Therapeutic agent for anxiety disorders | |
MY145122A (en) | Phenylacetic acid derivatives as cox-2 inhibitors |